INR Self-management In The LVAD Population: A Missed Opportunity?

Lauren Meece,Sean Kwak,Mohammad Al-Ani,Alex Parker,Juan Vilaro,Juan Aranda,Mustafa M. Ahmed

DOI: https://doi.org/10.1016/j.cardfail.2023.10.060

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:INTRODUCTION Therapeutic anticoagulation after left ventricular assist device (LVAD) implantation is crucial to prevent both thrombotic and bleeding complications. The introduction of point of care INR testing for home use improves both time in therapeutic range (TTR) and patient satisfaction among LVAD patients, and presents an opportunity to go beyond INR self-monitoring to patient self-management of vitamin K antagonists (VKA) dosing. However, the safety and effectiveness of VKA self-management, wherein patients are educated on appropriate dose adjustments which they then make independently, is unknown in this patient population. METHODS A comprehensive electronic search of PubMed, Embase, and CINAHL databases, as well as a review of meeting proceedings, was performed using key words “INR”, “VAD” and “self-management. The search was conducted in accordance with PRISMA guidelines, and included all available studies from database inception until March 2023. Studies were included if they investigated both INR self-monitoring and VKA self-management in the LVAD population, where LVAD patients titrated their dose of a VKA to achieve a therapeutic INR. Outcomes of interest included time in therapeutic range (TTR). RESULTS Of the 62 records retrieved, only 1 study involving 30 patients and 1798 INR measurements met inclusion criteria [Figure]. INR self-management had a higher TTR in comparison to a telemedicine anticoagulation service (78.1 ± 14.3% vs 58.3 ± 28.0%, p = 0.03). The 12 records related to self-management in the non-VAD population were also reviewed for further insight, yielding 9 studies involving 3650 patients across various disease entities. Of these, 6 demonstrated safety and/or non-inferiority with self INR management compared to standard anticoagulation services, while 3 demonstrated superior quality of anticoagulation with INR self-management. CONCLUSIONS INR self-management has been accomplished successfully across disease entities and may pose an opportunity to safely improve TTR among LVAD patients on VKAs. Further research is needed to assess the effects of VKA self-management on TTR as well as patient, caregiver and provider satisfaction within an LVAD population.

cardiac & cardiovascular systems